Skip to main content
. 2024 Mar 14;2024:8452050. doi: 10.1155/2024/8452050

Table 2.

Patient reported outcome scores.

Cohort Preop neck VAS 6-week neck VAS 3-month neck VAS 6-month neck VAS Preop vs 6-month scores (p value) Change (%) NM vs NMRT (p value)
NM 4.9 ± 3.0 2.7 ± 2.2 1.7 ± 2.2 1.7 ± 2.5 0.00 55.0 0.8
(95% CI 3.98–5.82) (95% CI 2.03–3.37) (95% CI 1.03–2.37) (95% CI 0.935–2.46)
NMRT 5.3 ± 2.7 2.1 ± 2.3 1.4 ± 1.9 1.4 ± 2.2 0.00 73.0
(95% CI 4.54–6.06) (95% CI 1.45–2.75) (95% CI 0.862–1.94) (95% CI 0.778–2.02)

Preop arm VASs 6-week arm VAS 3-month arm VAS 6-month neck

NM 6.6 ± 2.9 2.6 ± 2.4 1.6 ± 2.1 1.1 ± 1.7 0.00 59.0 0.76
(95% CI 5.71–7.49) (95% CI 1.87–3.33) (95% CI 0.97–2.24) (95% CI 0.58–1.62)
NMRT 5.5 ± 2.9 1.7 ± 2.2 1.3 ± 2.2 1.2 ± 1.8 0.0002 78.0
(95% CI 4.68–6.32) (95% CI 1.08–2.32) (95% CI 0.678–1.92) (95% CI 0.961–1.71)

Preop NDI 6-week NDI 3-month NDI 6-month NDI

NM 30.1 ± 16.3 17.5 ± 16.1 9.9 ± 8.8 7.3 ± 8.6 0.0009 76.0 0.85
(95% CI 27.1–36.9) (95% CI 12.6–22.4) (95% CI 7.21–12.6) (95% CI 4.67–9.93)
NMRT 32.0 ± 17.4 1.81 ± 17.0 10.8 ± 11.6 9.3 ± 14.4 0.004 70.0
(95% CI 27.1–36.9) (95% CI 13.3–22.9) (95% CI 7.52–14.1) (95% CI 5.23–13.4)

Preop physical SF-12 6-week physical SF-12 3-month physical SF-12 6-month physical SF-12

NM 36.7 ± 9.1 43.6 ± 9.9 46.6 ± 7.3 47.7 ± 6.3 0.003 23.0 0.79
(95% CI 33.9–39.5) (95% CI 40.6–46.6) (95% CI 44.4–48.8) (95% CI 45.8–49.6)
NMRT 33.4 ± 10.3 43.7 ± 10.8 46.0 ± 10.9 47.2 ± 9.7 0.002 29.0
(95% CI 30.5–36.3) (95% CI 40.6–46.8) (95% CI 43–49) (95% CI 44.3–49.7)

Preop mental SF-12 6-week mental SF-12 3-month mental SF-12 6-month mental SF-12

NM 42.9 ± 10.3 49.3 ± 8.3 49.8 ± 6.7 50.2 ± 5.9 0.001 13.0 0.33
(95% CI 40–45.8) (95% CI 46.8–51.8) (95% CI 47.8–51.8) (95% CI 48.4–52)
NMRT 45.0 ± 10.8 51.3 ± 7.96 52.9 ± 7.8 53.4 ± 8.6 0.001 16.0
(95% CI 40–45.8) (95% CI 49–53.5) (95% CI 50.7–55.1) (95% CI 51–55.8)

CI, confidence interval; NDI, Neck Disability Index; SF-12, 12-Item -Short Form Survey; VAS, visual analogue scale.